Location History:
- Berlin, DE (2014 - 2018)
- Berlin, DK (2019)
Company Filing History:
4 out of 8 
2 out of 2 
2 out of 1,371 
Years Active: 2014-2019
Title: The Innovative Contributions of Andreas Raab
Introduction
Andreas Raab is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of genetically modified organisms. With a total of 8 patents to his name, Raab's work has the potential to impact various applications in medicine and research.
Latest Patents
One of Raab's latest patents involves a microorganism designed for expressing a human membrane protein. This invention relates to an isolated, genetically modified, living non-mammal organism that exhibits increased HMG-CoA-reductase activity compared to the wild type. Additionally, it has reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The organism is characterized by increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention also encompasses various uses of such an organism, a test kit comprising the organism, and a membrane extract derived from it.
Career Highlights
Throughout his career, Raab has worked with several prominent companies, including Organobalance GmbH and Organobalance Medical AG. His expertise in biotechnology has allowed him to contribute to innovative projects that advance the understanding of genetic modifications and their applications.
Collaborations
Raab has collaborated with notable professionals in his field, including Christine Lang and Michael Schilling. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.
Conclusion
Andreas Raab's innovative work in the field of biotechnology, particularly through his patents and collaborations, showcases his commitment to advancing scientific knowledge and applications. His contributions are likely to have a lasting impact on the industry.